Published on
October 4, 2017
- 00:54 GMT
NewLink Genetics Prices Public Offering of Common Stock
AMES, Iowa, Oct. 03, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (“NewLink Genetics”) (Nasdaq:NLNK), a late-stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 5,000,000 shares of its common stock …
Distribution channels:
Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry
...
